Corrigendum: KDM3A inhibition ameliorates hyperglycemia-mediated myocardial injury by epigenetic modulation of nuclear factor kappa-B/P65.

MLA

Zhang, Bofang, et al. “Corrigendum: KDM3A Inhibition Ameliorates Hyperglycemia-Mediated Myocardial Injury by Epigenetic Modulation of Nuclear Factor Kappa-B/P65.” Frontiers in Cardiovascular Medicine, vol. 10, June 2023, p. 1231599. EBSCOhost, https://doi.org/10.3389/fcvm.2023.1231599.

APA

Zhang, B., Zhang, J., Liu, G., Guo, X., Liu, X., & Chen, J. (2023). Corrigendum: KDM3A inhibition ameliorates hyperglycemia-mediated myocardial injury by epigenetic modulation of nuclear factor kappa-B/P65. Frontiers in Cardiovascular Medicine, 10, 1231599. https://doi.org/10.3389/fcvm.2023.1231599

Chicago

Zhang, Bofang, Jing Zhang, Gen Liu, Xin Guo, Xiaopei Liu, and Jing Chen. 2023. “Corrigendum: KDM3A Inhibition Ameliorates Hyperglycemia-Mediated Myocardial Injury by Epigenetic Modulation of Nuclear Factor Kappa-B/P65.” Frontiers in Cardiovascular Medicine 10 (June): 1231599. doi:10.3389/fcvm.2023.1231599.